From diabetes treatment to weight loss: GLP-1 - the driver of Ozempic and Wegovy
Learn how GLP-1 receptor agonists like semaglutide moved from type 2 diabetes treatment to chronic weight management, and what the evidence says about Ozempic and Wegovy.
























































